{"entity":{"id":"4b112a51-e43d-591c-96d3-24e5b4129031","name":"TAO Fangfang","type":"Organization","kind":"company","jurisdiction":"HK","identifier":"icij:icijol-87578","risk":"MED","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director of","share":null,"asset":{"id":"80924fbd-a810-5f73-bb8f-160f08973052","name":"Lansen Pharmaceutical Holdings Limited","type":"Company","kind":"company"}},{"role":"director of","share":null,"asset":{"id":"64cf2645-1919-5101-b9a3-5de7e2e32cfe","name":"DRAGON DILIGENT HOLDINGS LIMITED","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/87578"}],"source":"corpus"}